Drugs for Central Nervous System Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Drugs for Central Nervous System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Central Nervous System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Central Nervous System Overall Market Size
2.1 Global Drugs for Central Nervous System Market Size: 2021 VS 2027
2.2 Global Drugs for Central Nervous System Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Drugs for Central Nervous System Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Drugs for Central Nervous System Players in Global Market
3.2 Top Global Drugs for Central Nervous System Companies Ranked by Revenue
3.3 Global Drugs for Central Nervous System Revenue by Companies
3.4 Global Drugs for Central Nervous System Sales by Companies
3.5 Global Drugs for Central Nervous System Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Drugs for Central Nervous System Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Drugs for Central Nervous System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Central Nervous System Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Central Nervous System Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Central Nervous System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Central Nervous System Market Size Markets, 2021 & 2027
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type - Global Drugs for Central Nervous System Revenue & Forecasts
4.2.1 By Type - Global Drugs for Central Nervous System Revenue, 2016-2021
4.2.2 By Type - Global Drugs for Central Nervous System Revenue, 2022-2027
4.2.3 By Type - Global Drugs for Central Nervous System Revenue Market Share, 2016-2027
4.3 By Type - Global Drugs for Central Nervous System Sales & Forecasts
4.3.1 By Type - Global Drugs for Central Nervous System Sales, 2016-2021
4.3.2 By Type - Global Drugs for Central Nervous System Sales, 2022-2027
4.3.3 By Type - Global Drugs for Central Nervous System Sales Market Share, 2016-2027
4.4 By Type - Global Drugs for Central Nervous System Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Central Nervous System Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application - Global Drugs for Central Nervous System Revenue & Forecasts
5.2.1 By Application - Global Drugs for Central Nervous System Revenue, 2016-2021
5.2.2 By Application - Global Drugs for Central Nervous System Revenue, 2022-2027
5.2.3 By Application - Global Drugs for Central Nervous System Revenue Market Share, 2016-2027
5.3 By Application - Global Drugs for Central Nervous System Sales & Forecasts
5.3.1 By Application - Global Drugs for Central Nervous System Sales, 2016-2021
5.3.2 By Application - Global Drugs for Central Nervous System Sales, 2022-2027
5.3.3 By Application - Global Drugs for Central Nervous System Sales Market Share, 2016-2027
5.4 By Application - Global Drugs for Central Nervous System Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Drugs for Central Nervous System Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Central Nervous System Revenue & Forecasts
6.2.1 By Region - Global Drugs for Central Nervous System Revenue, 2016-2021
6.2.2 By Region - Global Drugs for Central Nervous System Revenue, 2022-2027
6.2.3 By Region - Global Drugs for Central Nervous System Revenue Market Share, 2016-2027
6.3 By Region - Global Drugs for Central Nervous System Sales & Forecasts
6.3.1 By Region - Global Drugs for Central Nervous System Sales, 2016-2021
6.3.2 By Region - Global Drugs for Central Nervous System Sales, 2022-2027
6.3.3 By Region - Global Drugs for Central Nervous System Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Drugs for Central Nervous System Revenue, 2016-2027
6.4.2 By Country - North America Drugs for Central Nervous System Sales, 2016-2027
6.4.3 US Drugs for Central Nervous System Market Size, 2016-2027
6.4.4 Canada Drugs for Central Nervous System Market Size, 2016-2027
6.4.5 Mexico Drugs for Central Nervous System Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Drugs for Central Nervous System Revenue, 2016-2027
6.5.2 By Country - Europe Drugs for Central Nervous System Sales, 2016-2027
6.5.3 Germany Drugs for Central Nervous System Market Size, 2016-2027
6.5.4 France Drugs for Central Nervous System Market Size, 2016-2027
6.5.5 U.K. Drugs for Central Nervous System Market Size, 2016-2027
6.5.6 Italy Drugs for Central Nervous System Market Size, 2016-2027
6.5.7 Russia Drugs for Central Nervous System Market Size, 2016-2027
6.5.8 Nordic Countries Drugs for Central Nervous System Market Size, 2016-2027
6.5.9 Benelux Drugs for Central Nervous System Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Drugs for Central Nervous System Revenue, 2016-2027
6.6.2 By Region - Asia Drugs for Central Nervous System Sales, 2016-2027
6.6.3 China Drugs for Central Nervous System Market Size, 2016-2027
6.6.4 Japan Drugs for Central Nervous System Market Size, 2016-2027
6.6.5 South Korea Drugs for Central Nervous System Market Size, 2016-2027
6.6.6 Southeast Asia Drugs for Central Nervous System Market Size, 2016-2027
6.6.7 India Drugs for Central Nervous System Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Drugs for Central Nervous System Revenue, 2016-2027
6.7.2 By Country - South America Drugs for Central Nervous System Sales, 2016-2027
6.7.3 Brazil Drugs for Central Nervous System Market Size, 2016-2027
6.7.4 Argentina Drugs for Central Nervous System Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Drugs for Central Nervous System Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Drugs for Central Nervous System Sales, 2016-2027
6.8.3 Turkey Drugs for Central Nervous System Market Size, 2016-2027
6.8.4 Israel Drugs for Central Nervous System Market Size, 2016-2027
6.8.5 Saudi Arabia Drugs for Central Nervous System Market Size, 2016-2027
6.8.6 UAE Drugs for Central Nervous System Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Drugs for Central Nervous System Major Product Offerings
7.1.4 Biogen Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.1.5 Biogen Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Central Nervous System Major Product Offerings
7.2.4 Pfizer Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Teva
7.3.1 Teva Corporate Summary
7.3.2 Teva Business Overview
7.3.3 Teva Drugs for Central Nervous System Major Product Offerings
7.3.4 Teva Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.3.5 Teva Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Drugs for Central Nervous System Major Product Offerings
7.4.4 Novartis Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Drugs for Central Nervous System Major Product Offerings
7.5.4 Johnson & Johnson Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 EliLilly
7.6.1 EliLilly Corporate Summary
7.6.2 EliLilly Business Overview
7.6.3 EliLilly Drugs for Central Nervous System Major Product Offerings
7.6.4 EliLilly Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.6.5 EliLilly Key News
7.7 Otsuka
7.7.1 Otsuka Corporate Summary
7.7.2 Otsuka Business Overview
7.7.3 Otsuka Drugs for Central Nervous System Major Product Offerings
7.4.4 Otsuka Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.7.5 Otsuka Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Drugs for Central Nervous System Major Product Offerings
7.8.4 Merck Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.8.5 Merck Key News
7.9 AstraZeneca
7.9.1 AstraZeneca Corporate Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Drugs for Central Nervous System Major Product Offerings
7.9.4 AstraZeneca Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.9.5 AstraZeneca Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Drugs for Central Nervous System Major Product Offerings
7.10.4 Novartis Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.10.5 Novartis Key News
7.11 Takeda
7.11.1 Takeda Corporate Summary
7.11.2 Takeda Drugs for Central Nervous System Business Overview
7.11.3 Takeda Drugs for Central Nervous System Major Product Offerings
7.11.4 Takeda Drugs for Central Nervous System Sales and Revenue in Global (2016-2021)
7.11.5 Takeda Key News
8 Global Drugs for Central Nervous System Production Capacity, Analysis
8.1 Global Drugs for Central Nervous System Production Capacity, 2016-2027
8.2 Drugs for Central Nervous System Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Central Nervous System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Central Nervous System Supply Chain Analysis
10.1 Drugs for Central Nervous System Industry Value Chain
10.2 Drugs for Central Nervous System Upstream Market
10.3 Drugs for Central Nervous System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Central Nervous System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Drugs for Central Nervous System in Global Market
Table 2. Top Drugs for Central Nervous System Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Drugs for Central Nervous System Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Drugs for Central Nervous System Revenue Share by Companies, 2016-2021
Table 5. Global Drugs for Central Nervous System Sales by Companies, (K Units), 2016-2021
Table 6. Global Drugs for Central Nervous System Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Drugs for Central Nervous System Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Drugs for Central Nervous System Product Type
Table 9. List of Global Tier 1 Drugs for Central Nervous System Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Central Nervous System Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Drugs for Central Nervous System Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Drugs for Central Nervous System Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Drugs for Central Nervous System Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Drugs for Central Nervous System Sales (K Units), 2016-2021
Table 15. By Type - Global Drugs for Central Nervous System Sales (K Units), 2022-2027
Table 16. By Application - Global Drugs for Central Nervous System Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Drugs for Central Nervous System Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Drugs for Central Nervous System Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Drugs for Central Nervous System Sales (K Units), 2016-2021
Table 20. By Application - Global Drugs for Central Nervous System Sales (K Units), 2022-2027
Table 21. By Region - Global Drugs for Central Nervous System Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Drugs for Central Nervous System Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Drugs for Central Nervous System Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Drugs for Central Nervous System Sales (K Units), 2016-2021
Table 25. By Region - Global Drugs for Central Nervous System Sales (K Units), 2022-2027
Table 26. By Country - North America Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Drugs for Central Nervous System Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Drugs for Central Nervous System Sales, (K Units), 2016-2021
Table 29. By Country - North America Drugs for Central Nervous System Sales, (K Units), 2022-2027
Table 30. By Country - Europe Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Drugs for Central Nervous System Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Drugs for Central Nervous System Sales, (K Units), 2016-2021
Table 33. By Country - Europe Drugs for Central Nervous System Sales, (K Units), 2022-2027
Table 34. By Region - Asia Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Drugs for Central Nervous System Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Drugs for Central Nervous System Sales, (K Units), 2016-2021
Table 37. By Region - Asia Drugs for Central Nervous System Sales, (K Units), 2022-2027
Table 38. By Country - South America Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Drugs for Central Nervous System Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Drugs for Central Nervous System Sales, (K Units), 2016-2021
Table 41. By Country - South America Drugs for Central Nervous System Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Drugs for Central Nervous System Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Drugs for Central Nervous System Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Drugs for Central Nervous System Sales, (K Units), 2022-2027
Table 46. Biogen Corporate Summary
Table 47. Biogen Drugs for Central Nervous System Product Offerings
Table 48. Biogen Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Drugs for Central Nervous System Product Offerings
Table 51. Pfizer Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Teva Corporate Summary
Table 53. Teva Drugs for Central Nervous System Product Offerings
Table 54. Teva Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Novartis Corporate Summary
Table 56. Novartis Drugs for Central Nervous System Product Offerings
Table 57. Novartis Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Drugs for Central Nervous System Product Offerings
Table 60. Johnson & Johnson Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. EliLilly Corporate Summary
Table 62. EliLilly Drugs for Central Nervous System Product Offerings
Table 63. EliLilly Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Otsuka Corporate Summary
Table 65. Otsuka Drugs for Central Nervous System Product Offerings
Table 66. Otsuka Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Merck Corporate Summary
Table 68. Merck Drugs for Central Nervous System Product Offerings
Table 69. Merck Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. AstraZeneca Corporate Summary
Table 71. AstraZeneca Drugs for Central Nervous System Product Offerings
Table 72. AstraZeneca Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Novartis Corporate Summary
Table 74. Novartis Drugs for Central Nervous System Product Offerings
Table 75. Novartis Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Takeda Corporate Summary
Table 77. Takeda Drugs for Central Nervous System Product Offerings
Table 78. Takeda Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Drugs for Central Nervous System Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 80. Global Drugs for Central Nervous System Capacity Market Share of Key Manufacturers, 2019-2021
Table 81. Global Drugs for Central Nervous System Production by Region, 2016-2021 (K Units)
Table 82. Global Drugs for Central Nervous System Production by Region, 2022-2027 (K Units)
Table 83. Drugs for Central Nervous System Market Opportunities & Trends in Global Market
Table 84. Drugs for Central Nervous System Market Drivers in Global Market
Table 85. Drugs for Central Nervous System Market Restraints in Global Market
Table 86. Drugs for Central Nervous System Raw Materials
Table 87. Drugs for Central Nervous System Raw Materials Suppliers in Global Market
Table 88. Typical Drugs for Central Nervous System Downstream
Table 89. Drugs for Central Nervous System Downstream Clients in Global Market
Table 90. Drugs for Central Nervous System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drugs for Central Nervous System Segment by Type
Figure 2. Drugs for Central Nervous System Segment by Application
Figure 3. Global Drugs for Central Nervous System Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Central Nervous System Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Central Nervous System Revenue, 2016-2027 (US$, Mn)
Figure 7. Drugs for Central Nervous System Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Central Nervous System Revenue in 2020
Figure 9. By Type - Global Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 10. By Type - Global Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 11. By Type - Global Drugs for Central Nervous System Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 13. By Application - Global Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 14. By Application - Global Drugs for Central Nervous System Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 16. By Region - Global Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 17. By Country - North America Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 18. By Country - North America Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 19. US Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 24. Germany Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 25. France Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 33. China Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 37. India Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 39. By Country - South America Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 40. Brazil Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Drugs for Central Nervous System Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Drugs for Central Nervous System Sales Market Share, 2016-2027
Figure 44. Turkey Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Drugs for Central Nervous System Revenue, (US$, Mn), 2016-2027
Figure 48. Global Drugs for Central Nervous System Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Drugs for Central Nervous System by Region, 2020 VS 2027
Figure 50. Drugs for Central Nervous System Industry Value Chain
Figure 51. Marketing Channels

Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda